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TREATMENT APPLICATIONS
Cognitive Behavioural Therapy for Mood Disorders
Thomas D. Meyer and Jan Scott
Newcastle University, UK
Abstract. This paper provides a selected review of recent studies highlighting key aspects of
mood disorders research. Cognitivemodels and clinical trials of cognitive therapy of depression
are evolving and adapting to increase applicability to the spectrum of depressive symptoms
and syndromes experienced by clients, as well exploring beyond acute phase treatment to
relapse prevention. In contrast, cognitive models of bipolar disorders and the effectiveness of
the therapy are unclear and there are more questions than answers for researchers in this area.
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Introduction
Beck (2005) recently highlighted the breadth of research on cognitive models of
psychopathology and noted a substantial body of evidence supporting the theory of depression.
In contrast, cognitive behavioural therapy (CBT) for bipolar disorders (BP) is a “work in
progress”.
There are now a number of CBTs for mood disorders that follow the “theoretical
conceptualization-therapy development” framework including those predominantly focused
on learning theory or behavioural activation (BA), predominantly cognitive models such
as Cognitive Therapy (CT/CBT), and models incorporating additional elements such as
Cognitive Behavioural Analysis System Psychotherapy (CBASP) and Mindfulness-Based
CognitiveBehavioural Therapy (MCBT). Themajority fulfill the criteria for “well-established”
empirically supported therapy (EST). Recognition as an EST means the efficacy has been
established in two ormore carefully designedmethodologically reliable randomized controlled
trials (RCTs) that evaluate the treatment of a specific disorder. Whilst there are some concerns
about employing criteria mostly employed in pharmacotherapy research, it is partly because
the CBT community has been prepared to be judged by such standards that CBT, more than any
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other therapy, has a perceived evidence-base that ensures its inclusion in treatment guidelines
for mood disorders (e.g. National Institute of Clinical Excellence).
Space limitations dictate that we discuss selected recently published theory and therapy
research. Whilst we focus on RCT research, there is a great deal of empirical support for
CBT in the treatment of depression from open trials, case series and studies using other
methodologies (Scott and Beck, 2008). For unipolar disorders recent outcome and process
research is reviewed. In BP, outcome research and ongoing attempts to clarify the cognitive
model are explored.
Depression
Outcome research
A number of meta-analytic studies (e.g. Butler, Chapman, Foreman and Beck, 2006) show
that, compared to waiting list or placebo treatments, CBT is highly effective for depressive
disorders, but is equivalent or only marginal superior to other active treatments. Whether the
treatment effects maintain post-therapy is more difficult to determine as few CBT RCTs have
adequate statistical power to assess reliably durability of any gains at follow-up. Despite this,
Butler et al. (2006) concluded CBT has persistent benefits and reduces relapses in unipolar
depression. However, there are still limitations in our understanding and several issues need
to be addressed.
Ameliorating symptoms. Recent RCTs of CBT for depressive symptoms (cf. depression
meeting diagnostic criteria) are limited to comparisons with treatment as usual/waiting list. A
meta-analysis of seven studies (Cuijpers, Smit and van Straten, 2007), with most using CBT
approaches, found that significant post-therapy benefits were lost at 6 and 12-month follow-
up. Many individuals treated in primary care or non-specialist settings have undifferentiated,
mixed depressive symptoms not meeting diagnostic criteria. Thus, we need to explore further
which CBT approaches best meet their needs, identify the factors resulting in reduced benefit
post-therapy, and investigate the impact of therapists’ level of expertise.
Acute depressive syndromes. There is a good deal of consistent evidence to support the
efficacy of CBT, BT, and BA over waiting list, drug placebo, treatment as usual (TAU), or
other treatment control conditions (Wampold, Minami, Baskin and Cullen Tierney, 2002).
However, Wampold et al. reported more modest benefits for CBT over “attention control”
therapies. Who should receive CBT in preference to other EST or medication and/or how to
predict differential benefit still needs to be established (Scott and Beck, 2008).
Severe depression. Debate continues regarding the efficacy of CBT for severe depression
(Scott, 2000). Guidelines generally suggest pharmacotherapy plus CBT is preferable to CBT
alone. A recent two-centre placebo-controlled RCT suggested that although CBT showed
equal efficacy to antidepressants, this was mainly because therapy at one centre with a strong
clinical and research track record in CBT compensated for its reduced efficacy at the second
centre (DeRubeis et al., 2005).
CBT has been found to be more effective than inter-personal therapy (IPT) for some severe
depressions (Luty et al., 2007), but less effective than BA in others (Dimidjian et al., 2006).
Therapist expertise has been inadequately studied in RCTs for depression, but the available
evidence suggests that competency is positively associated with client outcomes in moderate
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to severe depression and/or more complex presentations (DeRubeis et al., 2005; Scott and
Beck, 2008). These studies also indicate that behavioural approaches are more beneficial
than predominantly cognitive or inter-personal approaches for some clients. Clearly these
findings need to be replicated, but they indicate that CBT for severe depression may require
modification to, for example, compensate for attentional impairments.
Chronic depression. Combined CBT and medication is recommended for chronic depression
in most treatment guidelines. For clients whose depression persists despite adequate
pharmacotherapy, adjunctive CBT results in significantly fewer relapses over 18 months,
with some benefits maintaining for up to 3 years post-CBT (Paykel et al., 1999, 2005). CBT
modified to focus more on rumination has produced encouraging results and the possibility of
briefer 8-session CBT (Watkins et al., 2007).
A large-scale RCT of CBASP in clients with >2 years of depression found equivalent
remission and recovery rates for therapy and antidepressants, but significantly better outcomes
for the combination (Keller et al., 2000). Further analysis shows that CBASP is efficacious for
medication non-responders (and vice versa). Thus, the strategy of “switching” is supported
empirically in chronic disorders (unlike in acute depression STAR∗D study). Interestingly,
CBASP alone is as effective as the combined treatment and more effective than medication in
a particular subgroup of individuals with a history of abuse and neglect.
Prevention of relapse and recurrence. A review of eight studies reported a 30% relapse rate
for CBT over 1–2 years compared with 60% for maintenance antidepressants (Gloaguen,
Cortraux, Cucherat and Blackburn, 1998). Critics have argued that the analysis did not
distinguish clients who continued with prophylactic medication from those who did not.
However, an RCT that addressed this issue still found that acute CBT-responders were less
likely to relapse over the following year (24%), compared with medication-responders who
either had their antidepressant withdrawn (69%) or continued on antidepressants (58%) (Hollon
et al., 2005).
Risk of recurrence is higher in individuals with many previous episodes, so Jarrett et al.’s
(2001) findings of greater benefit from acute plus maintenance CBT compared with acute
CBT are noteworthy. Bockting et al. (2005) found that CBT significantly reduced relapses
over 24 months in clients in remission with > 5 previous episodes (relapse 46% v 72%),
mirroring findings on MCBT in clients in remission with > 3 previous episodes (e.g. Ma and
Teasdale, 2004). Whilst these studies provide grounds for optimism, future studies of relapse
must recruit samples that give adequate statistical power to detect real differences during the
post-CBT rather than the acute phase.
Process research
Beyond establishing CBT efficacy and effectiveness, it is important to determine the
mechanisms, moderators and predictors of response. The alliance between therapist and client,
and the client’s pre-treatment expectations of effectiveness predict active engagement in, and
speed of improvement with CBT. However, finding specific answers to questions such as “How
does therapy work?”, “What determines/predicts the efficacy of therapy?”, and “How do we
target therapy more effectively?” are essential to the process of matching CBT to clients’ needs.
Some clinically observable and measurable phenomena that may relate to CBT outcome are
highlighted below.
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Tang and DeRubeis’ original work on “sudden gains” found that some depressed clients
undergoing CBT showed substantial symptom improvement in a single between-session
interval. Research confirms that these sudden gains usually occur early in therapy, are
associated with better long-term outcomes, and are not measurement artefacts (Tang,
DeRubeis, Hollon, Amsterdam and Shelton, 2007). So understanding this phenomenon may
increase our ability to prevent relapse. Hayes et al. (2007) investigated the phenomenon
of transient worsening and found that these “depression spikes” also predicted lower post-
treatment depression. Weekly diaries also indicated that clients with spikes show more
cognitive-emotional processing during this period of arousal than those without. This study
confirms the clinical observation that transient worsening is not necessarily indicative of poor
outcome.
Several studies have indicated that changes in the processing of depression-related
information rather than in thought content may be important in the mechanism of action
of CBT. Teasdale et al. (2000) reported that CBT modifies the form of thinking in chronic
depression and reductions in all-or-nothing thinking style mediated its relapse prevention
effect. This is consistent with the notion that CBT helps clients to acquire compensatory or
meta-cognitive skills, hinting that shifting the mode of processing may be the critical factor.
Studies have also found that improvements in a specific cognitive skill, “situational analysis”,
early in CBT predicted level of depression at termination.
Fresco, Segal, Buis and Kennedy (2007) found that CBT-responders exhibited significantly
greater gains in “de-centring” compared with antidepressant-responders and that high levels of
de-centring post-CBT was associated with the lower relapse rates at 18 months. The findings of
an experimental study by Singer and Dobson (2007) involving depressed patients in remission
suggest that preventative interventions may operate by reducing the intensity of sad moods
and altering one’s attitudes towards and/or acceptance of temporary moments of sadness.
The above gives a snap-shot of recent process research, but it is important to acknowledge
Hollon, Stewart and Strunk’s (2006) comments that we remain uncertain whether the durable
benefits of CBT are a consequence of the amelioration of the causal processes that generate
risk or the introduction of compensatory strategies that offset them, and it is unclear whether
these effects reflect the mobilization of cognitive or of other mechanisms.
Bipolar disorders
RCTs of BP have regarded CBT as an adjunct to medication/TAU rather than an alternative.
A brief selective review of the available evidence and a discussion of the limitations of the
current cognitive model are provided below.
Outcome research
There have been eight RCTs of CBT for relapse prevention since Cochran’s (1984) small but
successful brief intervention to enhance lithium adherence. We review a selection, starting
with the only unequivocal findings to date (Lam et al., 2000, 2003). Lam reports two RCTs of
CBT plus TAU vs TAU alone for stably remitted BP clients. Only 44% of clients treated with
CBT had a relapse within a year, compared with 75% in the control (Lam et al., 2003). The
benefit of CBT plus TAU was maintained to an extent at 2-year follow-up, but between group
differences were only apparent for depression and faded over time (Lam, Hayward, Watkins,
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Wright and Sham, 2005). A problem for CBT, evident in this and other studies, is that 20–25
CBT sessions targeted even at remitted clients have relatively circumscribed, time-limited
prophylactic effects. Furthermore, it is unclear if any observed benefits are due to specific
formulation-driven interventions or result from generic psychoeducation approaches. Recent
relapse prevention studies from Canada (e.g. Zaretsky, Segal and Gemar, 1999) report that
seven sessions of psychoeducation are as equally effective at 12 months as seven sessions of
psychoeducation plus 13 sessions of CBT. Likewise, Meyer and Hautzinger (2005) compared
20 sessions of CBT with 20 of supportive therapy and found 12-month relapse rates of 50%
in both groups, with few specific differences between CBT and supportive therapy.
Scott, Garland and Moorhead (2001) and Scott et al. (2006) used a formulation-based CBT
approach to address specific individual problems with BP, focusing on acute symptoms as
well as relapse prevention. In a pilot study, CBT showed greater reductions in depression,
with a trend towards fewer remissions and more relapses in the control group. However, in the
largest CBT RCT so far (n = 254), adjunctive therapy was not superior to TAU (Scott et al.,
2006). Reasons for the lack of treatment effect might relate to the pragmatic 5-centre design
of the trial that specifically targeted general adult clients at very high risk of relapse. The
authors concluded that when treating BP in routine clinical settings, 22 sessions of CBT were
inadequate. A post-hoc analysis showed that individuals at an earlier stage of their BP career
benefited significantly more from CBT compared to TAU; and those with fewer episodes
showed significantly lower relapse rates in the CBT condition.
There are no RCTs of CBT for hypomania/mania, but two publications explore CBT for
acute bipolar depression. In a non-randomized comparison, Zaretsky et al. (1999) showed
significant improvements in depression in clients with BP that were comparable with changes
for a unipolar depression group. However, unlike the unipolar group, there was no significant
change in dysfunctional attitudes in the bipolar group. A recent large RCT of bipolar depression
explored the benefits of 30 sessions of adjunctive CBT, modified IPT, or family focused
treatment with a 6-session collaborative care approach (Miklowitz et al., 2007). All three
therapies led to faster and more frequent remission than collaborative care, but the initial
report only included the 3-month post-therapy follow-up, so we do not yet know if therapy
gains are maintained.
Cognitive models for bipolar disorders
Given the inconsistent and sometimes disappointing findings for CBT in BP, it is relevant
to review the robustness of cognitive models for onset and relapse. Early models lacked an
adequate theoretical framework to explain how cognitive vulnerability to mood disorders (e.g.
underlying dysfunctional beliefs) could precipitate depression at certain times but mania at
another. Also, most early interventions, even when labelled as CBT, consisted of generic
interventions to prevent relapse. Despite the acknowledgement that mania and depression
might be associated with different risk factors (e.g. Johnson, 2005; Meyer and Maier, 2006),
there is still little empirical research that explains this dual vulnerability. Furthermore, in BP,
elevated levels of dysfunctional attitudes and/or negative thoughts are often epiphenomena of
sub-syndromal depression (e.g. Jones et al., 2005; Lex, Meyer, Marquat and Thau, 2008) that
is frequent and represents the main symptom burden in BP (e.g. Mansell, Colom and Scott,
2005). Also, cognitive models often present mania as the polar opposite of depression, but the
elated mania prototype is less common than dysphoric, irritable or labile forms.
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More sophisticated models of mania/hypomania have recently been proposed that take
these issues into account (e.g. Jones, 2001). Approaches adopting a similar strategy as for
bipolar depression, by trying to specify mania-related cognitions and dysfunctional attitudes,
have found evidence that global and stable attributions for success and failure can increase
symptoms of depression and mania in individuals “at risk” for, but without diagnosed BP
(e.g. Alloy, Reilly-Harrington, Fresco, Whitehouse and Zechmeister, 1999). Observed
disruptions in circadian rhythms has led to hypotheses that misattributions of associated
biological dysrhythmias (e.g. decreased sleep) trigger a spiral of behavioural activation and/or
changes in mood and self-esteem that progress to a mania-like state (e.g. Scott, 2007; Meyer,
in press). Further, goal-related cognitions and a “hyper-positive sense of self” are proposed
as specific triggers/personality styles that increase the risk of manic relapse (e.g. Johnson,
2005: Lam, Wright and Sham, 2005). Analogue studies of ascent into mania (e.g. Johnson,
Ruggero and Carver, 2005; Meyer and Maier, 2006) offer opportunities to examine cognitive
processes without potential confounds such as medication or hospitalizations; however, such
findings only have validity for dimensional models of mania. The latter have utility for the
bipolar spectrum, but current thinking on mania increasingly identifies activation level rather
than mood state or cognitive shift as the primary determinant of polarity of bipolar relapse.
This is likely to mean that cognitive interventions will be targeted at modifying dispositional
or situational cognitions that arise at the beginning of a relapse prodrome rather than there
being a classic mania-vulnerability triad. In the end, CBT may well be better targeted at the
type II variant of BP, where the clinical picture is dominated by acute depression and residual
symptoms that are only partially responsive to medications (Mansell et al., 2005).
Concluding comments
Kraemer, Wilson, Fairburn and Agras (2002) suggest that RCTs should now routinely include
an evaluation of the mediators and moderators of outcomes. This is an attractive proposition for
studies of depressive disorders, but is premature for BP where more detailed theoretical work
and coherent modelling are required to produce CBT interventions with greater specificity
and durability. Research in mood disorders is advancing towards exploration of the mind-
brain interface with fMRI scanning studies of those receiving CBT or medication to look
at the locus and process of change in cognitive-emotional networks. With a few exceptions
(e.g. Goldapple et al., 2004) this research is biased by allocation of subjects to preferred
treatments and a paucity of pre-study hypotheses. Nonetheless, there are the beginnings of
consistency in differential observed patterns of changes with CBT and medication that opens
up exciting opportunities for future empirical research on the neuro-scientific underpinnings
of CBT (Miterschiffthaler, Williams, Scott and Fu, 2008).
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